S. D. Girolamo

KRAS and BRAF mutational status as selective criteria for targeted therapy in cholangiocarcinoma.

G. Brandi, M. Fiorentino, A. Altimari, 2010 .

Intestinal microbiota around colorectal cancer genesis

G. Liguori, G. Brandi, P. Raibaud, 2013 .

Asbestos exposure in patients affected by bile duct tumours

G. Ercolani, G. Grazi, F. Belpoggi, 2008 .

Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients?

G. Brandi, P. Caraceni, L. Calzà, 2013, Liver international : official journal of the International Association for the Study of the Liver.

Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases

G. Brandi, G. Ercolani, G. Grazi, 2012, Langenbeck's Archives of Surgery.